Literature DB >> 24134524

Quasispecies tropism and compartmentalization in gut and peripheral blood during early and chronic phases of HIV-1 infection: possible correlation with immune activation markers.

G Rozera1, I Abbate, C Vlassi, E Giombini, R Lionetti, M Selleri, P Zaccaro, B Bartolini, A Corpolongo, G D'Offizi, A Baiocchini, F Del Nonno, G Ippolito, M R Capobianchi.   

Abstract

HIV quasispecies was analysed in plasma and proviral genomes hosted by duodenal mucosa and peripheral blood cells (PBMC) from patients with early or chronic infection, with respect to viral heterogeneity, tropism compartmentalization and extent of immune activation. Seventeen HIV-1-infected combined antiretroviral therapy naive patients were enrolled (11 early infection and six chronic infection). V3 and nef genomic regions were analysed by ultra-deep pyrosequencing. Sequences were used to infer co-receptor usage and to construct phylogenetic trees. As markers of immune activation, plasma sCD14 and soluble tumour necrosis factor receptor II (sTNFRII) levels were measured. Median diversity of HIV RNA was lower in patients with early infection versus chronic infection patients. Overall, direct correlation was observed between V3 diversity and X4 frequency; V3 diversity of HIV RNA was inversely correlated with CD4 T-cell count; median sCD14 and sTNFRII values were similar in early and chronic patients, but X4 frequency of HIV RNA was directly correlated with plasma sCD14. The proportion of patients harbouring X4 variants and median intra-patient X4 frequency of proviral genomes tended to be higher in chronic infection than early infection patients. More pronounced compartmentalization of proviral quasispecies in gut compared with PBMC samples was observed in patients with early infection compared with chronic patients. The loss of gut/PBMC compartmentalization in more advanced stages of HIV infection was confirmed by longitudinal observation. More studies are needed to understand the pathogenetic significance of early HIV quasispecies compartmentalization and progressive intermixing of viral variants in subsequent phases of the infection, as well as the role of immune activation in tropism switch.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Compartmentalization; HIV quasispecies; co-receptor usage; gut mucosa; immune activation markers; viral diversity

Mesh:

Substances:

Year:  2013        PMID: 24134524     DOI: 10.1111/1469-0691.12367

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  12 in total

1.  Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.

Authors:  Emily C Liang; Lindsay Sceats; Nicholas L Bayless; Dara M Strauss-Albee; Jessica Kubo; Philip M Grant; David Furman; Manisha Desai; David A Katzenstein; Mark M Davis; Andrew R Zolopa; Catherine A Blish
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

2.  Multiplexed highly-accurate DNA sequencing of closely-related HIV-1 variants using continuous long reads from single molecule, real-time sequencing.

Authors:  Dario A Dilernia; Jung-Ting Chien; Daniela C Monaco; Michael P S Brown; Zachary Ende; Martin J Deymier; Ling Yue; Ellen E Paxinos; Susan Allen; Alfredo Tirado-Ramos; Eric Hunter
Journal:  Nucleic Acids Res       Date:  2015-06-22       Impact factor: 16.971

3.  Role of Tunneling Nanotube-like Structures during the Early Events of HIV Infection: Novel Features of Tissue Compartmentalization and Mechanism of HIV Spread.

Authors:  George Okafo; Silvana Valdebenito; Maribel Donoso; Ross Luu; David Ajasin; Brendan Prideaux; Santhi Gorantla; Eliseo A Eugenin
Journal:  J Immunol       Date:  2020-10-09       Impact factor: 5.422

4.  V-pipe: a computational pipeline for assessing viral genetic diversity from high-throughput data.

Authors:  Susana Posada-Céspedes; David Seifert; Ivan Topolsky; Kim Philipp Jablonski; Karin J Metzner; Niko Beerenwinkel
Journal:  Bioinformatics       Date:  2021-01-20       Impact factor: 6.937

5.  A spatio-temporal assessment of simian/human immunodeficiency virus (SHIV) evolution reveals a highly dynamic process within the host.

Authors:  Alison F Feder; Christopher Kline; Patricia Polacino; Mackenzie Cottrell; Angela D M Kashuba; Brandon F Keele; Shiu-Lok Hu; Dmitri A Petrov; Pleuni S Pennings; Zandrea Ambrose
Journal:  PLoS Pathog       Date:  2017-05-25       Impact factor: 6.823

6.  Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation.

Authors:  Marta E Bull; Caroline Mitchell; Jaime Soria; Sheila Styrchak; Corey Williams-Wietzikoski; Jillian Legard; Jennifer McKernan-Mullin; Kelli Kraft; Frankline Onchiri; Joshua Stern; Sarah Holte; Kevin J Ryan; Edward P Acosta; Alberto La Rosa; Robert W Coombs; Eduardo Ticona; Lisa M Frenkel
Journal:  AIDS       Date:  2018-07-17       Impact factor: 4.177

7.  Hepatitis E Virus Shows More Genomic Alterations in Cell Culture than In Vivo.

Authors:  Gulce Sari; Martijn D B van de Garde; Anne van Schoonhoven; Jolanda J C Voermans; Annemiek A van der Eijk; Robert A de Man; Andre Boonstra; Thomas Vanwolleghem; Suzan D Pas
Journal:  Pathogens       Date:  2019-11-22

8.  Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy.

Authors:  Mary F Kearney; Elizabeth M Anderson; Charles Coomer; Luke Smith; Wei Shao; Nicholas Johnson; Christopher Kline; Jonathan Spindler; John W Mellors; John M Coffin; Zandrea Ambrose
Journal:  Retrovirology       Date:  2015-11-11       Impact factor: 4.602

9.  HIV Impairs Lung Epithelial Integrity and Enters the Epithelium to Promote Chronic Lung Inflammation.

Authors:  Kieran A Brune; Fernanda Ferreira; Pooja Mandke; Eric Chau; Neil R Aggarwal; Franco R D'Alessio; Allison A Lambert; Gregory Kirk; Joel Blankson; M Bradley Drummond; Athe M Tsibris; Venkataramana K Sidhaye
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

10.  Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy.

Authors:  Jenny L Anderson; Gabriela Khoury; Rémi Fromentin; Ajantha Solomon; Nicolas Chomont; Elizabeth Sinclair; Jeffrey M Milush; Wendy Hartogensis; Peter Bacchetti; Michael Roche; Carolin Tumpach; Matthew Gartner; Matthew C Pitman; Christine Lorrie Epling; Rebecca Hoh; Frederick M Hecht; Ma Somsouk; Paul U Cameron; Steven G Deeks; Sharon R Lewin
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.